Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction
about
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseOcular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in RatsAngiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats.PI3K/AKT signaling pathway plays a role in enhancement of eNOS activity by recombinant human angiotensin converting enzyme 2 in human umbilical vein endothelial cells.ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injuryACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.Short-term treatment with diminazene aceturate ameliorates the reduction in kidney ACE2 activity in rats with subtotal nephrectomy.Angiotensin converting enzyme 2: a new important player in the regulation of glycemia.Activation of endogenous angiotensin converting enzyme 2 prevents early injuries induced by hyperglycemia in rat retina.Angiotensin-converting enzyme 2 activation improves endothelial functionRole of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureAntiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitroOpportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system.Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications.Increase of angiotensin-converting enzyme activity and peripheral sympathetic dysfunction could contribute to hypertension development in streptozotocin-induced diabetic rats.Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats.The effects of chronic candesartan treatment on cardiac and hepatic adenosine monophosphate-activated protein kinase in rats submitted to surgical stress.The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy.Cardioprotective effect of virgin coconut oil in heated palm oil diet-induced hypertensive rats
P2860
Q28077454-4AF4ED02-8B7C-46B7-B256-CD62924FAEC9Q28546739-46D78A6B-63C5-4612-B871-FB6BE07090FFQ33648557-148CE565-FC68-4204-BDF0-6EF701D2B555Q34733168-B4268E79-D736-40D4-8ABD-0A14B6712389Q34866649-887BE446-FC3F-4F1B-BC57-AF551699FBE6Q35138448-9A0DBD55-5920-4A62-90D0-04F0F86DE58BQ35192530-C0096D60-B1A1-4531-B777-3CB72061A43BQ36020040-E7B59AB4-75B8-4635-81E8-5D785898E860Q36322296-1D8461DA-43D1-4BBA-9FDA-1077F9FB2F6BQ37069541-14F6B703-1D52-4323-ABC4-15B438A19261Q37081415-7044BDCF-85C7-4649-956A-71928EF38BB7Q37085063-F6D55907-0FEF-41F5-AF63-8A9F0ACF0641Q37731227-A52C6384-9572-4B38-AE44-B65F2256B1FEQ38065112-EE346EAA-1306-4DF2-B480-1ABD0EB21F83Q38069197-73F3675C-F37E-4F7F-8C18-9DFE5EDA66ACQ38170474-AADBE214-EAC4-4F32-A9BF-6FA6DA3409EDQ44008076-D819627B-2CD0-41EB-9028-9C247A9BB031Q45193547-61CD61B6-41EE-458F-8012-1DC72B40D2B9Q47768588-22BC09F5-20F9-4E80-9B65-DB8603BC2FC6Q47851502-B644E720-2EB2-4424-8C1F-F8942E1AC675Q55294754-3CCC509C-CB1F-4D63-BAD6-56B44577D19BQ56611333-0E5B51C5-320B-4E1D-99F4-1CB07BAE7B41
P2860
Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction
description
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
scientific journal article
@en
vedecký článok (publikovaný 2012/08/20)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd op 2012/08/20)
@nl
наукова стаття, опублікована в серпні 2012
@uk
مقالة علمية (نشرت في 20-8-2012)
@ar
name
Oral administration of an angi ...... es-induced cardiac dysfunction
@ast
Oral administration of an angi ...... es-induced cardiac dysfunction
@en
Oral administration of an angi ...... es-induced cardiac dysfunction
@nl
type
label
Oral administration of an angi ...... es-induced cardiac dysfunction
@ast
Oral administration of an angi ...... es-induced cardiac dysfunction
@en
Oral administration of an angi ...... es-induced cardiac dysfunction
@nl
prefLabel
Oral administration of an angi ...... es-induced cardiac dysfunction
@ast
Oral administration of an angi ...... es-induced cardiac dysfunction
@en
Oral administration of an angi ...... es-induced cardiac dysfunction
@nl
P2093
P2860
P3181
P1433
P1476
Oral administration of an angi ...... es-induced cardiac dysfunction
@en
P2093
Anderson J. Ferreira
Carolina A. B. Capuruço
Marcos B. Melo
Michael J. Katovich
Mohan K. Raizada
Patrícia L. Moraes
Robson A. S. Santos
Sérgio H. S. Santos
Tatiane M. Murça
Vinayak Shenoy
P2860
P304
P3181
P356
10.1016/J.REGPEP.2012.05.093
P577
2012-08-20T00:00:00Z